Join
Live feed
·
INSIDERFilingvia Quantisnow
MoonLake Immunotherapeutics logo

Chief Financial Officer Bodenstedt Matthias converted options into 294,473 units of Class A ordinary shares and returned 294,473 units of Class C ordinary shares to the company, closing all direct ownership in the company (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
MLTX· MoonLake Immunotherapeutics
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MLTX (MoonLake Immunotherapeutics) and more on Quantisnow.